Suggested

Trending

Melanoma Rates Decline Found in Younger Population
0:03:21

Melanoma Rates Decline Found in Younger Population
6 Views
4 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Tamer Othman, MD on Trends of Adult Acute Lymphoblastic Leukemia @tamerothman10 @HarborUCLA #leukemia #ALL
0:02:55

Tamer Othman, MD on Trends of Adult Acute Lymphoblastic Leukemia @tamerothman10 @HarborUCLA #leukemia #ALL
4 Views
1 week ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
TOURMALINE-AL1 Study @MayoClinic
0:01:14

TOURMALINE-AL1 Study @MayoClinic
1 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
New Evidence from Large Studies Highlights Value of Oncotype DX Breast Recurrence Score® to Guide Chemotherapy Treatment in Young Patients with Node-negative or Node-positive Early-stage...

New Evidence from Large Studies Highlights Value of Oncotype DX Breast Recurrence Score® to Guide Chemotherapy Treatment in Young Patients with Node-negative or Node-positive Early-stage...
18 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Latest Videos

Prakash Bhuyan, MD on VGX-3100 Efficacy Results and Important Points @InovioPharma
0:03:04

Prakash Bhuyan, MD on VGX-3100 Efficacy Results and Important Points @InovioPharma
Other Free
3 Views
10 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Prakash Bhuyan, MD on VGX-3100 In The Current Treatment? @InovioPharma
0:02:49

Prakash Bhuyan, MD on VGX-3100 In The Current Treatment? @InovioPharma
Other Free
4 Views
10 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Prakash Bhuyan, MD on Phase 2 VGX-3100 Results In HPV-associated Anal Dysplasia @InovioPharma
0:06:02

Prakash Bhuyan, MD on Phase 2 VGX-3100 Results In HPV-associated Anal Dysplasia @InovioPharma
Other Free
3 Views
11 hours ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Venetoclax-Rituximab (VenR) in Relapsed Refractory (R R) CLL How This Affects Clinicians #ASH19 #ASH
0:01:57

Venetoclax-Rituximab (VenR) in Relapsed Refractory (R R) CLL How This Affects Clinicians #ASH19 #ASH
1 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login